1. Home
  2. MRUS vs HUBG Comparison

MRUS vs HUBG Comparison

Compare MRUS & HUBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • HUBG
  • Stock Information
  • Founded
  • MRUS 2003
  • HUBG 1971
  • Country
  • MRUS Netherlands
  • HUBG United States
  • Employees
  • MRUS N/A
  • HUBG N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • HUBG Oil Refining/Marketing
  • Sector
  • MRUS Health Care
  • HUBG Consumer Discretionary
  • Exchange
  • MRUS Nasdaq
  • HUBG Nasdaq
  • Market Cap
  • MRUS 2.7B
  • HUBG 2.0B
  • IPO Year
  • MRUS 2016
  • HUBG 1996
  • Fundamental
  • Price
  • MRUS $42.77
  • HUBG $33.13
  • Analyst Decision
  • MRUS Strong Buy
  • HUBG Buy
  • Analyst Count
  • MRUS 14
  • HUBG 8
  • Target Price
  • MRUS $87.00
  • HUBG $47.13
  • AVG Volume (30 Days)
  • MRUS 786.0K
  • HUBG 618.9K
  • Earning Date
  • MRUS 05-07-2025
  • HUBG 05-08-2025
  • Dividend Yield
  • MRUS N/A
  • HUBG 1.51%
  • EPS Growth
  • MRUS N/A
  • HUBG N/A
  • EPS
  • MRUS N/A
  • HUBG 1.70
  • Revenue
  • MRUS $54,732,000.00
  • HUBG $3,946,390,000.00
  • Revenue This Year
  • MRUS $26.81
  • HUBG $4.73
  • Revenue Next Year
  • MRUS $23.85
  • HUBG $7.07
  • P/E Ratio
  • MRUS N/A
  • HUBG $19.49
  • Revenue Growth
  • MRUS N/A
  • HUBG N/A
  • 52 Week Low
  • MRUS $33.19
  • HUBG $30.75
  • 52 Week High
  • MRUS $61.61
  • HUBG $53.21
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 49.60
  • HUBG 48.69
  • Support Level
  • MRUS $37.92
  • HUBG $30.75
  • Resistance Level
  • MRUS $46.36
  • HUBG $33.30
  • Average True Range (ATR)
  • MRUS 2.56
  • HUBG 1.04
  • MACD
  • MRUS -0.22
  • HUBG 0.26
  • Stochastic Oscillator
  • MRUS 57.46
  • HUBG 68.79

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About HUBG Hub Group Inc.

Hub Group ranks among the largest providers of rail intermodal service. Roughly 60% of consolidated revenue comes from Hub's intermodal and transportation solutions division. ITS includes its flagship intermodal operations, which use the Class I rail carriers for the underlying line-haul movement of containers, as well as its dedicated truckload shipping unit. Hub's logistics segment includes its asset light truck brokerage operations, along with its outsourced transportation management, warehousing and fulfillment, and heavy-goods final mile delivery offerings. Hub is somewhat acquisitive in that it often makes tuck-in acquisitions which expand its brokerage, last-mile, and dedicated offerings.

Share on Social Networks: